These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15774734)

  • 21. Tenofovir: a pill to prevent HIV?
    Bonn D
    Lancet Infect Dis; 2005 Feb; 5(2):78. PubMed ID: 15702509
    [No Abstract]   [Full Text] [Related]  

  • 22. Tenofovir helps prevent HIV in drug users.
    BMJ; 2013 Jun; 346():f3871. PubMed ID: 23777811
    [No Abstract]   [Full Text] [Related]  

  • 23. Prophylactic tenofovir reduced HIV infection in injectable drug users.
    Bender BS
    Ann Intern Med; 2013 Sep; 159(6):JC8. PubMed ID: 24042391
    [No Abstract]   [Full Text] [Related]  

  • 24. Preemptive use of antiretroviral drugs to prevent sexual transmission of HIV to high-risk uninfected MSM.
    Gross M
    Am J Public Health; 2003 Aug; 93(8):1200. PubMed ID: 12893587
    [No Abstract]   [Full Text] [Related]  

  • 25. Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: current considerations in light of new findings.
    Myers GM; Mayer KH
    AIDS Patient Care STDS; 2011 Feb; 25(2):63-71. PubMed ID: 21284497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV transmission may be prevented by intravaginal tenofovir ring.
    Parks L
    Future Med Chem; 2012 Dec; 4(18):2239. PubMed ID: 23359902
    [No Abstract]   [Full Text] [Related]  

  • 27. Tenofovir ready for approval.
    AIDS Patient Care STDS; 2001 Jul; 15(7):399. PubMed ID: 11483167
    [No Abstract]   [Full Text] [Related]  

  • 28. Tolerability of two different combinations of antiretroviral drugs including tenofovir used in occupational and nonoccupational postexposure prophylaxis for HIV.
    Burty C; Prazuck T; Truchetet F; Christian B; Penalba C; Salmon-Ceron D; Yazdanpanah Y; May T; Rabaud C
    AIDS Patient Care STDS; 2010 Jan; 24(1):1-3. PubMed ID: 20095911
    [No Abstract]   [Full Text] [Related]  

  • 29. HIV antiretroviral prophylaxis for injecting drug users.
    Craig AP; Gray R; Jansson J; Wilson DP
    Lancet; 2013 Sep; 382(9895):854-5. PubMed ID: 24012263
    [No Abstract]   [Full Text] [Related]  

  • 30. HIV antiretroviral prophylaxis for injecting drug users.
    Miller WC; Hoffman IF; Latkin CA; Strathdee SA; Shoptaw S
    Lancet; 2013 Sep; 382(9895):853. PubMed ID: 24012262
    [No Abstract]   [Full Text] [Related]  

  • 31. HIV antiretroviral prophylaxis for injecting drug users.
    Hudgens MG; Cole SR
    Lancet; 2013 Sep; 382(9895):853. PubMed ID: 24012261
    [No Abstract]   [Full Text] [Related]  

  • 32. HIV antiretroviral prophylaxis for injecting drug users.
    Zhiliang H; Yongfeng Y
    Lancet; 2013 Sep; 382(9895):853-4. PubMed ID: 24012260
    [No Abstract]   [Full Text] [Related]  

  • 33. HIV antiretroviral prophylaxis for injecting drug users - Authors' reply.
    Choopanya K; Martin M; Vanichseni S; Mock PA; Suntharasamai P; Sangkum U
    Lancet; 2013 Sep; 382(9895):855. PubMed ID: 24012264
    [No Abstract]   [Full Text] [Related]  

  • 34. Preexposure prophylaxis reduces HIV risk in injection-drug users.
    Rosenberg K
    Am J Nurs; 2013 Sep; 113(9):17. PubMed ID: 23985594
    [No Abstract]   [Full Text] [Related]  

  • 35. [3 years' data of tenofovir. Confirmed as a valuable building block].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():30-1. PubMed ID: 15373042
    [No Abstract]   [Full Text] [Related]  

  • 36. Less than the sum of its parts: failure of a tenofovir-abacavir-Lamivudine triple-nucleoside regimen.
    Kuritzkes DR
    J Infect Dis; 2005 Dec; 192(11):1867-8. PubMed ID: 16267755
    [No Abstract]   [Full Text] [Related]  

  • 37. What they say about: nucleotide drugs.
    Posit Aware; 2000; 11(1):55. PubMed ID: 11366352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current data on antiretroviral therapy. CROI 2009: tenofovir DR convinces by high effectiveness and tolerance].
    Walter M
    MMW Fortschr Med; 2009 Apr; 151(18):76-9. PubMed ID: 19769084
    [No Abstract]   [Full Text] [Related]  

  • 39. Antiretroviral prophylaxis for HIV prevention reaches a key milestone.
    Karim SS; Karim QA
    Lancet; 2012 Jun; 379(9831):2047-8. PubMed ID: 22608193
    [No Abstract]   [Full Text] [Related]  

  • 40. Tenofovir, equivalence, and noninferiority.
    Parienti JJ
    JAMA; 2004 Oct; 292(16):1951; author reply 1951-2. PubMed ID: 15507576
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.